Cologne Court Prohibits Prescription Issuance via Online Questionnaires

The Regional Court of Cologne has ruled against the practice of issuing prescriptions for medications based solely on online questionnaires. The court determined that such procedures do not align with recognized medical standards and are therefore unlawful in Germany.

The case centered on the promotion and operation of online platforms that offered users the ability to obtain prescriptions for certain medications, particularly those for erectile dysfunction, through a simple digital questionnaire. Advertisements suggested that users could receive prescriptions in a matter of minutes by answering a series of questions online. After clicking on these ads, users were redirected to the website of a well-known pharmacy operator, where they would complete an age verification and then proceed to a telemedicine platform affiliated with the pharmacy. There, a digital questionnaire was used to gather information from the user, which would then serve as the basis for a prescription. The prescribed medication could subsequently be supplied directly by the same pharmacy.

The court identified several issues with this model. Most notably, it found that the use of non-validated questionnaires without a physical examination does not meet the professional standards required for safe and effective medical care. The ruling was informed by expert testimony that emphasized the necessity of a physical examination to determine the underlying causes of conditions such as erectile dysfunction. The court concluded that a diagnosis made solely through a questionnaire is insufficient, as current medical guidelines require a more comprehensive assessment, including a physical examination, to ensure accurate diagnosis and appropriate treatment.

Furthermore, the court found that the advertising methods employed by the pharmacy and its telemedicine partner were misleading and in breach of regulations. It was determined that promoting rapid, questionnaire-based prescriptions risked undermining the medical safeguards put in place to protect patients' health. The court emphasized that medical guidelines and the obligation to prescribe only after a thorough assessment are designed not only to prevent harm but also to ensure that patients receive the most suitable care for their specific health issues.

The court also addressed the argument made by the companies involved, which suggested that no harm would occur even in instances where a prescription was not medically indicated. The court rejected this reasoning, clarifying that the aim of professional medical standards is not merely to avoid harm, but to guarantee that patients are offered appropriate and effective treatments following accepted procedures.

In addition, the court described as unethical the notion that a healthy patient, who may not wish to undergo a physical examination, could be provided with a prescription based solely on a digital questionnaire. It highlighted that prescription requirements and medical standards exist not just for regulatory compliance, but also to protect individuals from potential risks, including those they may not fully appreciate themselves.

This ruling has significant implications for the growing field of telemedicine and online pharmaceutical services in Germany. It underscores the necessity for telemedicine providers to adhere to established medical protocols, including comprehensive patient evaluations, before issuing prescriptions. The court's decision serves as a warning for digital health platforms and pharmacies, reinforcing the importance of upholding medical standards in the interest of patient safety.

The outcome is expected to influence how telemedicine services operate in the future, particularly with regard to prescription medications that require thorough clinical evaluation. Industry stakeholders are now called upon to review their procedures to ensure compliance with legal and ethical guidelines governing medical care and pharmaceutical dispensing.